This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
Genomic Health Inc
GHDX : NASDAQ : Health Care
$32.28 -0.10 | -0.31%
Today's Range: 32.21 - 33.66
Avg. Daily Volume: 158,100
01/30/15 - 3:59 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
GHDX GENOMIC HEALTH INC 32.48 1030.33 n/m 275.40 8.76
KPTI KARYOPHARM THERAPEUTICS INC 26.34 938.81 n/m 0.24 n/a
SGMO SANGAMO BIOSCIENCES INC 13.37 914.56 n/m 37.79 44.24
MGNX MACROGENICS INC 32.60 906.12 n/m 57.23 182.85
RGLS REGULUS THERAPEUTICS INC 18.26 887.51 n/m 8.90 -48.69
ARIA ARIAD PHARMACEUTICALS INC 6.20 1160.71 n/m 46.93 25.87
NLNK NEWLINK GENETICS CORP 39.24 1097.15 n/m 3.64 231.60
LGND LIGAND PHARMACEUTICAL INC 55.83 1096.84 174.47 56.28 17.55
EBS EMERGENT BIOSOLUTIONS INC 28.91 1085.63 60.23 400.27 29.43
MACK MERRIMACK PHARMACEUTICALS 9.82 1039.78 n/m 76.67 41.58
ARNA ARENA PHARMACEUTICALS INC 4.66 1027.36 n/m 34.30 -55.36
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

GHDX Ind Avg S&P 500
n/m 83.11 19.47

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Top Rated Stocks Top Rated Funds Top Rated ETFs